Related Experiment Video

Updated: Sep 10, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.4K

Dendritic siRNA conjugate riding albumin for targeted delivery to solid tumors

Brady Wang1, Jason T Gatlin1, Puneet Anand1

  • 1Regeneron Genetic Medicines, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.

Molecular Therapy. Nucleic Acids
|August 21, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K

Related Experiment Videos

Last Updated: Sep 10, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.4K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

Ligase-mediated programmable genomic integration (L-PGI).

Nature communications·2025

Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver.

Journal of medicinal chemistry·2025

RNA Interference Therapeutics for Hereditary Amyloidosis: A Narrative Review of Clinical Trial Outcomes and Future Directions.

Cureus·2024

The Psychosocial Effects of Lockdown Due to the COVID-19 Pandemic on Children in 2021.

Cureus·2024

Identification of a Selective SCoR2 Inhibitor That Protects Against Acute Kidney Injury.

Journal of medicinal chemistry·2023

AKR1A1 is a novel mammalian S-nitroso-glutathione reductase.

The Journal of biological chemistry·2019

MicroRNA-sensing plasmid system for dynamic control of functional ion channel expression.

Molecular therapy. Nucleic acids·2026

Kinetics, thermodynamics, and mechanisms of PMO interactions from computational molecular modeling.

Molecular therapy. Nucleic acids·2026

Focal ischemia induces genome-wide accumulation of R-loops in the brain.

Molecular therapy. Nucleic acids·2026

Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis.

Molecular therapy. Nucleic acids·2026

Long-read target enrichment sequencing for rAAV integration site analysis in engineered clones with targeted viral insertion.

Molecular therapy. Nucleic acids·2026

ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity.

Molecular therapy. Nucleic acids·2026

Mucus-Penetrating Nanostructured Lipid Carriers: An Effective Approach for Cannabidiol to Pass Across the Nasal Mucus-Mucosal Barrier.

Journal of biomedical materials research. Part A·2026

Research progress on nanoplatforms for in vivo miRNA detection over the past decade.

Mikrochimica acta·2026

Bioluminescence-based high-throughput screening and identification of direct-acting dengue virus NS5 methyltransferase inhibitors.

International journal of biological macromolecules·2026

Intranasal immunization in mice with spore-associated serine-aspartate repeat-containing protein D from Staphylococcus aureus secreted in Bacillus subtilis.

Biotechnology letters·2026

Marinobufagenin and left ventricular mass and geometry in patients with essential hypertension.

Journal of hypertension·2026

Nanotechnology-Driven Ultrasound/Photoacoustic Theranostics for Real-Time Imaging and Therapeutics.

Nanotheranostics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us